No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CLB240719C15000
- 5.30
- +0.70+15.22%
15min DelayClose Jul 5 15:59 ET
5.30High5.30Low
5.30Open4.60Pre Close2 Volume2 Open Interest15.00Strike Price1.06KTurnover45.79%IV0.15%PremiumJul 19, 2024Expiry Date5.27Intrinsic Value100Multiplier13DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.9997Delta0.0006Gamma3.82Leverage Ratio-0.0022Theta0.0057Rho3.82Eff Leverage0.0000Vega
Intraday
- 5D
- Daily
News
CORE LABORATORIES' SECOND QUARTER 2024 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON JULY 25, 2024
Core Laboratories (NYSE: "CLB") will broadcast its second quarter 2024 conference call over the Internet at 7:30 a.m. CDT / 8:30 a.m. EDT on July 25, ...
We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might
Is Core Laboratories Inc.'s (NYSE:CLB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Ariel Focus Fund Expecting Moderate Growth in Core Laboratories NV (CLB)
Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?
Is There An Opportunity With Core Laboratories Inc.'s (NYSE:CLB) 26% Undervaluation?
Comments
Core Laboratories' declining ROCE trend signals a mature business possibly facing new competition or smaller margins. Unless metrics shift positively, consider other investment opportunities.
Analysts are more negative on Core Laboratories after recent results, leading to a minor EPS downgrade for next year. Despite this, the unchanged consensus price target suggests lower forecast earnings won't affect the stock price. However, the company's revenue growth is expected to lag the industry average.
Despite Core Laboratories' move to profitability, the ongoing drop in revenue and share price indicates negative market sentiment. Investors are urged to consider other factors before investing.
Investors project strong growth for Core Laboratories given the high P/E ratio, showing confidence in the company's future earnings. Other investment risks should also be considered while investing, not just the P/E ratio.
Read more